Advisor Group Holdings, Inc. Tekla Life Sciences Investors Transaction History
Advisor Group Holdings, Inc.
- $52.6 Billion
- Q2 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 30,459 shares of HQL stock, worth $511,711. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,459
Previous 14,696
107.26%
Holding current value
$511,711
Previous $188,000
107.45%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding HQL
# of Institutions
87Shares Held
9.88MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.02MShares$50.7 Million0.99% of portfolio
-
Penserra Capital Management LLC Orinda, CA794KShares$13.3 Million0.16% of portfolio
-
Morgan Stanley New York, NY766KShares$12.9 Million0.0% of portfolio
-
Royal Bank Of Canada Toronto, A6451KShares$7.58 Million0.0% of portfolio
-
Karpus Management, Inc. Pittsford, NY431KShares$7.24 Million0.23% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...